|
Volumn 400, Issue B, 1997, Pages 825-830
|
Tumor radiosensitization based on the use of inhibitors of the mevalonate pathway of cholesterol synthesis
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CHOLESTEROL;
COBALT 60;
LIMONENE;
METHIONINE;
MEVALONIC ACID;
MEVINOLIN;
PROTEIN P21;
RADIOSENSITIZING AGENT;
SULFUR 35;
CANCER RADIOTHERAPY;
CELL SURVIVAL;
CHOLESTEROL SYNTHESIS;
COBALT THERAPY;
CONFERENCE PAPER;
CONTROLLED STUDY;
GENE MUTATION;
HUMAN;
HUMAN CELL;
ISOPRENYLATION;
ONCOGENE RAS;
POLYACRYLAMIDE GEL ELECTROPHORESIS;
PRIORITY JOURNAL;
RADIATION DOSE;
RADIOSENSITIZATION;
ADENOCARCINOMA;
BRAIN NEOPLASMS;
BREAST NEOPLASMS;
CELL SURVIVAL;
CHOLESTEROL;
COBALT RADIOISOTOPES;
COLONIC NEOPLASMS;
CYCLIN-DEPENDENT KINASE INHIBITOR P21;
CYCLINS;
CYCLOHEXENES;
DOSE-RESPONSE RELATIONSHIP, RADIATION;
FEMALE;
FIBROSARCOMA;
GAMMA RAYS;
GENES, RAS;
GLIOBLASTOMA;
HUMANS;
LUNG NEOPLASMS;
MALE;
MEVALONIC ACID;
PROSTATIC NEOPLASMS;
RADIATION-SENSITIZING AGENTS;
TERPENES;
TUMOR CELLS, CULTURED;
|
EID: 0031418493
PISSN: 00652598
EISSN: None
Source Type: Book Series
DOI: None Document Type: Article |
Times cited : (3)
|
References (10)
|